• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

5-氟尿嘧啶联合放疗用于头颈癌治疗

5-fluorouracil plus radiation for head and neck cancer.

作者信息

Stupp R, Vokes E E

机构信息

Department of Medicine, University of Chicago, Illinois, USA.

出版信息

J Infus Chemother. 1995 Spring;5(2):55-60.

PMID:8521235
Abstract

5-fluorouracil is a widely used chemotherapeutic agent. Its role and activity in the treatment of squamous cell carcinoma of the head and neck are reviewed. In head and neck cancer, 5-fluorouracil is mostly used in combination with cisplatin. Despite a high activity of this regimen, as documented in response rates of up to 90%, its use as an adjuvant to surgery and radiation does not impact consistently on survival rates. In contrast, 5-FU-based chemotherapy with concomitant radiotherapy seems to improve treatment outcome. Several randomized trials suggest improved locoregional control with concomitant chemoradiotherapy with a 5-fluorouracil-based chemotherapy regimen. The activity and the metabolism of 5-FU can be further modulated by cisplatin, hydroxyurea, and leucovorin.

摘要

5-氟尿嘧啶是一种广泛应用的化疗药物。本文综述了其在头颈部鳞状细胞癌治疗中的作用和活性。在头颈部癌中,5-氟尿嘧啶大多与顺铂联合使用。尽管该方案活性较高,缓解率高达90%,但其作为手术和放疗的辅助治疗对生存率并无持续影响。相比之下,以5-氟尿嘧啶为基础的化疗联合放疗似乎能改善治疗效果。多项随机试验表明,采用以5-氟尿嘧啶为基础的化疗方案同步放化疗可改善局部区域控制情况。顺铂、羟基脲和亚叶酸可进一步调节5-氟尿嘧啶的活性和代谢。

相似文献

1
5-fluorouracil plus radiation for head and neck cancer.5-氟尿嘧啶联合放疗用于头颈癌治疗
J Infus Chemother. 1995 Spring;5(2):55-60.
2
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer.紫杉醇、5-氟尿嘧啶、羟基脲及同步放疗用于预后不良的头颈癌治疗
Semin Radiat Oncol. 1999 Apr;9(2 Suppl 1):70-6.
3
[Chemoradiotherapy for patients with advanced head and neck cancer].[晚期头颈癌患者的放化疗]
Gan To Kagaku Ryoho. 1997 Nov;24(14):2049-57.
4
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.顺铂、氟尿嘧啶和亚叶酸钙诱导化疗后联合顺铂同步放化疗用于晚期头颈癌患者的器官保留及治愈:长期随访
J Clin Oncol. 2004 Aug 1;22(15):3061-9. doi: 10.1200/JCO.2004.01.108.
5
Induction chemotherapy followed by concomitant chemoradiation therapy in advanced head and neck cancer: a phase II study for organ-sparing purposes evaluating feasibility, effectiveness and toxicity.晚期头颈癌诱导化疗后序贯同步放化疗:一项以器官保留为目的的II期研究,评估可行性、有效性和毒性。
Int J Oncol. 2002 Feb;20(2):419-27.
6
The role of low dose cisplatin plus 5-fluorouracil for treatment of recurrent and/or advanced squamous cell carcinoma of the head and neck.低剂量顺铂联合5-氟尿嘧啶在治疗复发性和/或晚期头颈部鳞状细胞癌中的作用。
Gan To Kagaku Ryoho. 2000 May;27 Suppl 2:592-9.
7
[Advances in the treatment of head and neck tumors. 2. Radiochemotherapy].
Strahlenther Onkol. 1995 Mar;171(3):140-8.
8
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.多中心随机II期研究:对于晚期头颈癌,采用紫杉醇(1小时输注)、氟尿嘧啶、羟基脲,并联合每日两次放疗,同时比较加用或不加用促红细胞生成素的疗效。
Clin Cancer Res. 2003 May;9(5):1689-97.
9
Feasibility trial of postoperative radiotherapy and cisplatin followed by three courses of 5-FU and cisplatin in patients with resected head and neck cancer: a Southwest Oncology Group study.
Cancer J Sci Am. 1999 Sep-Oct;5(5):307-11.
10
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.药代动力学调节化疗联合顺铂作为可切除局部晚期头颈癌诱导化疗的疗效:II期研究
Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15.